NASDAQ · Biotechnology

ORMP (ORMP) Stock

$4.94 -1.59% NASDAQ: ORMP Healthcare

Valuation

MetricValue
Price$4.94
Market Cap$202.17M
P/E Ratio2.85
P/B Ratio0.87
P/S Ratio86.55
EPS (TTM)$1.50
52-Week High$5.39
52-Week Low$1.98
Dividend Yield5.84%

Financials & Margins

MetricValue
ROE32.00%
ROA27.71%
ROCE-7.50%
Gross Margin-750.00%
Operating Margin-750.00%
Net Margin3200.00%
Debt/Equity0.01
Current Ratio7.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.0M$3.0M$1.0M$0$2.0M
Operating Profit$-24.0M$-41.0M$-16.0M$-13.0M$-15.0M
Net Profit$-22.0M$-38.0M$6.0M$-19.0M$64.0M
EPS$-0.78$-0.97$0.14$-0.47$1.50
Op Margin-896.1%-1502.0%-1176.8%—-754.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$128.0M$162.0M$221.0M$155.0M$231.0M
Total Liabilities$11.0M$10.0M$58.0M$10.0M$31.0M
Cash$77.0M$40.0M$9.0M$54.0M$46.0M
Borrowings$1.0M$1.0M$52.0M$0$1.0M

Latest News

Lifeward Enters Securities Purchase Agreement Under Oramed Financing Framework MT Newswires · Jul 7, 2026 Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing GlobeNewswire · Jul 7, 2026 Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet PR Newswire · Jun 25, 2026 ORMP: View Inclusion in Russell Indexes as Positive That Could Raise Awareness in Investment Community Zacks Small Cap Research · Jun 18, 2026 Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes PR Newswire · Jun 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-21.0M$-29.0M$-10.0M$-8.0M$-9.0M
Investing Cash Flow$-23.0M$30.0M$-73.0M$106.0M$4.0M
Financing Cash Flow$0$0$0$-2.0M$-5.0M
Net Cash Flow$58.0M$-37.0M$-31.0M$45.0M$-8.0M
Free Cash Flow$-22.0M$-29.0M$-11.0M$-8.0M$-11.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-7.24%
Quick Ratio6.45
Interest Coverage—
Return 1Y101.44%
Return 3Y33.67%
Return 5Y-66.21%

Ownership

Insiders Held17.93%
Institutions Held31.65%
Institutions Float Held38.57%
Institutional HolderSharesReport Date
BML Capital Management, LLC3,167,2312026-03-31
Aquamarine Financial (cayman) Ltd2,112,3122026-03-31
Mercer Global Advisors, Inc./ADV1,910,5402026-03-31
Gem Investment Advisors, LLC1,640,0692026-03-31
Murchinson Ltd.1,315,2942026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CLNN $4.24 -0.93% -1.31 $54.18M 0.00%
CNTB $2.35 +6.82% -2.31 $147.97M 0.00%
CNTX $0.36 -7.44% -6.84 $33.14M 0.00%
COYA $4.52 -0.88% -2.62 $106.03M 0.00%
IFRX $2.25 +5.40% -4.16 $330.67M 0.00%

About ORMP

ORMP is led by CEO Nadav Kidron, employs 13 people, headquartered in US, publicly traded since 2007.

ORMP stock trades at $4.94 with a market capitalization of $202.17M. The stock is valued at a price-to-earnings (P/E) ratio of 2.85, price-to-book of 0.87, price-to-sales of 86.55. Over the past 52 weeks the stock has ranged between $1.98 and $5.39, and currently trades 8.3% below its 52-week high. It pays a dividend yielding 5.84%.

On profitability, ORMP generates a return on equity (ROE) of 32.00% — well above the market average, a sign of a high-quality business, return on capital employed of -7.50%, an operating margin of -750.00%, a net profit margin of 3200.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1163.29 +0.57% JNJ Drug Manufacturers - General $270.06 +1.58% ABBV Drug Manufacturers - General $261.00 +1.79% MRK Drug Manufacturers - General $149.18 +0.96% UNH Medical - Healthcare Plans $395.72 +1.62% NVS Drug Manufacturers - General $161.63 +6.29% AZN Drug Manufacturers - General $161.97 -0.10% AMGN Drug Manufacturers - General $437.27 +1.72% TMO Medical - Diagnostics & Research $601.84 -2.47% NVO Biotechnology $45.25 -0.18% ABT Medical - Devices $109.56 -0.72% GILD Drug Manufacturers - General $149.07 +1.86%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides